India  

'Probing Indian cough syrup': WHO after 66 children die in Gambia

DNA Wednesday, 5 October 2022
WHO said it is conducting further investigation with the Indian company and regulatory authorities in India.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Cough Syrup [Video]

Cough Syrup

In the Gambia, parents react to the recent measures taken by the authorities to stop the import of cough syrups that have been linked to the deaths of 69 children in the country. "If it is due..

Credit: Rumble     Duration: 04:28Published
Cough Syrup in Gambia [Video]

Cough Syrup in Gambia

In the Gambia, parents react to the recent measures taken by the authorities to stop the import of cough syrups that have been linked to the deaths of 69 children in the country. "If it is due..

Credit: Rumble     Duration: 04:28Published
WHO: 4 Indian cough syrups being probed after 66 children die in Gambia|Oneindia news *International [Video]

WHO: 4 Indian cough syrups being probed after 66 children die in Gambia|Oneindia news *International

The World Health Organisation on Wednesday warned that four "contaminated" and "substandard" cough syrups, allegedly produced by Maiden Pharmaceuticals Limited based in Haryana's Sonipat could be the..

Credit: Oneindia     Duration: 02:22Published

Related news from verified sources

Firm behind Gambia child deaths a repeat offender in India

The Central Drug Standard Control Organisation (CDSCO) has been quick to assure people that the cough syrup which killed 66 children in Gambia was not being sold...
IndiaTimes

Haryana STOPS cough syrup production by Maiden Pharma linked to 66 child deaths in Gambia

Earlier on Monday, the Indian Pharma company had released a statement over the reports linking its cough syrups to the deaths of 66 children in Gambia.  
Zee News